Literature DB >> 6702471

Point prevalence of major depressive disorder in a Swedish urban female population.

T Hällström.   

Abstract

In a representative sample of 800 women in Gothenburg, aged 38-54 years, the point prevalence of major depressive episode according to DSM-III criteria was 6.9%. Of these, 2.9% had a melancholic episode and 4.0% a non-melancholic. There was no age difference between the two groups. The episode duration was less than a year in 65% of both groups. Mean age at initial episode was significantly lower in the melancholic (33.3 years) than in the non-melancholic group (38.7). The melancholics presented symptoms of mental disorder before age 20 in 39% of cases as against 18% of the non-melancholics. None of the depressives had had a manic episode. The prevalence rate of 6.9% is of the same magnitude as rates recently found in other industrialized countries when standardized diagnostic criteria are used. The earlier onset of melancholic major depression might be indicative of etiological differences between melancholic and non-melancholic major depression.

Entities:  

Mesh:

Year:  1984        PMID: 6702471     DOI: 10.1111/j.1600-0447.1984.tb04516.x

Source DB:  PubMed          Journal:  Acta Psychiatr Scand        ISSN: 0001-690X            Impact factor:   6.392


  3 in total

1.  A 37-year prospective study of neuroticism and extraversion in women followed from mid-life to late life.

Authors:  E Billstedt; I Skoog; P Duberstein; T Marlow; T Hällström; M André; L Lissner; C Björkelund; S Ostling; M Waern
Journal:  Acta Psychiatr Scand       Date:  2013-02-19       Impact factor: 6.392

2.  Changes in women's sexual desire in middle life: the longitudinal study of women in Gothenburg.

Authors:  T Hällström; S Samuelsson
Journal:  Arch Sex Behav       Date:  1990-06

3.  Prevalence of depression in a 55-year-old Finnish population.

Authors:  U Rajala; A Uusimäki; S Keinänen-Kiukaanniemi; S L Kivelä
Journal:  Soc Psychiatry Psychiatr Epidemiol       Date:  1994-05       Impact factor: 4.328

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.